CIBC World Market
IRD

CIBC World Market’s Opus Genetics IRD Stock Holding History

CIBC World Market’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-42
Closed -$10K – 943
2015
Q3 		$10K Hold
42
– – ﹤0.01% 860
2015
Q2 		$12K Buy
+42
New +$14.3K ﹤0.01% 890

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BMC
Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return

CIBC World Market's IRD Position: Q4 2015 in Review

CIBC World Market sold out of Opus Genetics (IRD) in Q4 2015, closing a stake of 42 shares — an estimated $10K sold.

CIBC World Market first reported a position in IRD in Q2 2015 and held it in 2 quarters. The position peaked at $12K in Q2 2015. 34 funds tracked by Wall St. Rank hold IRD as of Q4 2015.

  • CIBC World Market reported no remaining Opus Genetics position as of Q4 2015 after selling out during the quarter.
  • CIBC World Market sold 42 Opus Genetics shares in Q4 2015, an estimated $10K.
  • CIBC World Market first reported a position in Opus Genetics in Q2 2015 and held it in 2 quarters.
  • CIBC World Market's Opus Genetics position peaked at $12K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2015.

Based on CIBC World Market's 13F filing for Q4 2015, filed 14 Jan 2016.